Alfresa Holdings to Enhance Governance with New Committee Structure

An update from Alfresa Holdings ( (JP:2784) ) is now available.

Alfresa Holdings Corporation has announced a transition to a company with an audit and supervisory committee structure to enhance its corporate governance. This change aims to improve management decision-making and corporate value by separating business supervision from execution and strengthening the Board of Directors’ monitoring functions.

More about Alfresa Holdings

The Alfresa Group is a leader in the Japanese healthcare industry, focusing on ethical pharmaceuticals wholesaling, OTC pharmaceuticals wholesaling, pharmaceutical manufacturing, and operating dispensing pharmacies. The company aims to fulfill its corporate philosophy of creating and delivering a fresh life for all.

YTD Price Performance: -3.61%

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $2.66B

For an in-depth examination of 2784 stock, go to TipRanks’ Stock Analysis page.